Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients

Version 1 : Received: 27 July 2023 / Approved: 27 July 2023 / Online: 28 July 2023 (09:23:56 CEST)

A peer-reviewed article of this Preprint also exists.

Juríčková, V.; Fayette, D.; Jonáš, J.; Fajnerová, I.; Kozák, T.; Horáček, J. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients. Curr. Oncol. 2023, 30, 9028-9038. Juríčková, V.; Fayette, D.; Jonáš, J.; Fajnerová, I.; Kozák, T.; Horáček, J. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients. Curr. Oncol. 2023, 30, 9028-9038.

Abstract

Background: Cancer-related cognitive impairment (CRCI) is one of the most serious side effects of cancer that negatively impact the quality of life of cancer patients and survivors. There is evidence of CRCI in Hodgkin lymphoma patients (HL); however, there is a lack of studies examining the presence of cognitive deficits before starting any treatment in HL patients. Methods: Forty patients (N=40) newly diagnosed with HL (with no previous cancer diagnoses) and 40 healthy controls (N=40) matched for age, sex, education, and premorbid intellect completed the neuropsychological battery and subjective and objective measures of affective distress and quality of life. Results: The results showed impairment in three out of six cognitive domains: verbal memory and learning, speed of processing/ psychomotor speed, and abstraction/executive functions in the HL patients before the initiation of any treatment. Speed of processing/psychomotor speed domain negatively correlated with depression. Conclusion: Impairment in verbal memory and learning and abstraction/executive functions domains in HL patients seems to occur before the initiation of treatment independently of anxiety, depression, or physical symptoms. This suggests that HL itself may cause cognitive deficits in these cognitive domains. However, the underlying causes of CRCI still remain unclear.

Keywords

Cancer-related cognitive impairment; Hodgkin lymphoma; neuropsychology; affective distress; quality of life

Subject

Medicine and Pharmacology, Hematology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.